Achieving Adherence to Glaucoma Medications: Are We There Yet? is organized by Healio, Vindico Medical Education.
Release Date: August 30, 2023
Expiration Date: August 31, 2024
Activity Description:
Optimal clinical outcomes in the medical management of patients with glaucoma are dependent upon adherence to therapy. Unfortunately, adherence to glaucoma therapies is low, with estimates that up to 50% of patients fail to receive the intended benefits of treatment and risk worsening of disease. Many barriers have been identified that influence patient compliance, including a lack of tolerability to therapies containing preservatives. However, antiglaucoma medications with alternative or no preservatives are currently available, and others that have the potential to improve tolerability by minimizing damage to the ocular surface are in development. In this CE monograph, experts in the field review medications used as first-line therapy for glaucoma, including their efficacy, safety, and tolerability, as well as assess available and emerging first-line therapies that may lessen damage to the ocular surface and increase tolerability.
Learning Objective:
Upon successful completion of this activity, participants should be better able to:
• Review medications used as first-line therapy for glaucoma, including their efficacy, safety, and tolerability.
• Assess available and emerging first-line glaucoma therapies that may lessen damage to the ocular surface and improve tolerability.